Recombinant Human Interleukin-11 Treatment Enhances Collateral Vessel Growth After Femoral Artery Ligation

Authors
Publication date
1 January 2011
Publisher
Doi

    Abstract

    We investigated the role of recombinant human interleukin-11 (rhIL-11) on in vivo mobilization of CD34+/VEGFR2+ mononuclear cells and collateral vessel remodeling in mouse model of hindlimb ischemia

      Similar works

      Full text

      thumbnail-image

      Available Versions

      Carolina Digital Repository

      redirect
      oaicdr.lib.unc.edu:vh53x2945
      Last time updated on 24/11/2020